
What it isCardioselective beta-1 adrenergic antagonist with partial beta-2 agonist and mild vasodilatory activity.
Why this oneUsed outside the US for hypertension and shown to reduce arterial events in vascular Ehlers-Danlos syndrome.
What limits itP-glycoprotein and OATP substrate whose absorption is reduced by food and by transporter-modulating drugs.
NO BOXED WARNINGS
Principal riskNo FDA boxed warning.
Open Celiprolol in the interactive console ↗